DMAC20261016C2.5
DMAC Oct 16 2026 2.50 Call (DMAC261016C00002500)
option OPRA

diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.